Northwestern University supports the concept of a randomized clinical trial to determine risks and accuracy of chorionic villus sampling. The sole unit in the Chicago area in which investigators are both geneticists and obstetricians, and the largest prenatal diagnostic center in the region, we have a well-defined referral base that will facilitate identification of women early in pregnancy who are willing to be randomized. Since March 1984 we have been monitoring continuing pregnancies, and by January 1985 over 100 will have been studied. To help achieve the NICHD goal, we propose identifying at least 20 subjects per month who are 8-11 weeks pregnant, have viable pregnancies on ultrasound, and have no factors predisposing to fetal wastage (Form A). After randomization into two groups (chorionic villus sampling vs amniocentesis), we will detail medical history, prior pregnancies, genetic history and socioeconomic factors (Forms B,C,D). Subjects randomized in the chorionic villus group will undergo the procedure at 8-11 weeks. Ultrasound will be performed one week thereafter, and again at 16 weeks. Pregnancy complications will be recorded at 4-week intervals throughout gestation. Maternal stress will be assessed upon entry, at 24 weeks and upon termination (delivery or fetal loss). The amniocentesis group will undergo that procedure at 16 weeks, having an ultrasound one week later and surveillance further, as described above. All fetal losses will be subjected to chromosomal studies and anatomic dissection, with DNA analysis or metabolic assays if appropriate. Placenta and cord will be thoroughly examined (Form J) and within two weeks major and minor anomalies determined by geneticists (Form K). Neonatal development will be assessed at nine months, and long-term maternal complications at one and two years. Diagnostic accuracy and laboratory quality will be on the basis of recording technical details (Forms L and M). Finally, women insistent upon CVS will be followed to allow comparison with those agreeing to randomization. Provisions for recruiting controls are made, should attempts at randomization be unsuccessful. All data will be recorded on standard forms, 16 of which are provided in detail in this proposal.

Project Start
1986-06-01
Project End
1989-06-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Matsumoto, H; Ma , W; Smalley, W et al. (2001) Diversification of cyclooxygenase-2-derived prostaglandins in ovulation and implantation. Biol Reprod 64:1557-65
Scherle, P A; Ma, W; Lim, H et al. (2000) Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem 275:37086-92
Tharapel, A T; Jaswaney, V L; Dockter, M E et al. (1993) Inability to detect fetal metaphases in flow-sorted lymphocyte cultures based on maternal-fetal HLA differences. Fetal Diagn Ther 8:95-101
Qumsiyeh, M B; Tharapel, A T; Shulman, L P et al. (1990) Anaphase lag as the most likely mechanism for monosomy X in direct cytotrophoblasts but not in mesenchymal core cells from the same villi. J Med Genet 27:780-1
Shulman, L P; Tharapel, A T; Meyers, C M et al. (1990) Direct analysis of uncultured cytotrophoblastic cells from second- and third-trimester placentas: an accurate and rapid method for detection of fetal chromosome abnormalities. Am J Obstet Gynecol 163:1606-9
Tharapel, A T; Moretti, M L; Meyers, C M et al. (1990) Diagnosis of trisomy 18 using spontaneously dividing cells from fetal umbilical cord blood: a novel approach for rapid late second and third trimester prenatal diagnosis. Am J Perinatol 7:211-3
Youssef, M; Shulman, L P; Tharapel, A T et al. (1990) Failure to document fetal cells in maternal circulation using the Selypes-Lorencz ""air-culture"" cytogenetic technique. Hum Genet 85:133-4
Tipton, R E; Tharapel, A T; Chang, H H et al. (1989) Rapid chromosome analysis with the use of spontaneously dividing cells derived from umbilical cord blood (fetal and neonatal). Am J Obstet Gynecol 161:1546-8
Tharapel, A T; Elias, S; Shulman, L P et al. (1989) Resorbed co-twin as an explanation for discrepant chorionic villus results: non-mosaic 47,XX,+16 in villi (direct and culture) with normal (46,XX) amniotic fluid and neonatal blood. Prenat Diagn 9:467-72
Shulman, L P; Ling, F W; Meyers, C M et al. (1989) Dilatation and evacuation is a preferable method for mid-trimester genetic termination of pregnancy. Prenat Diagn 9:741-2